Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette G Beck-Sickinger

Showing results (81-90 of 309) with videos related to

Pageof 31
Sort By:
Future Medicinal Chemistry|August 25, 2012
Peptides and peptide conjugates: therapeutics on the upward pathVerena M Ahrens, Kathrin Bellmann-Sickert, Annette G Beck-Sickinger
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 6, 2009
First selective agonist of the neuropeptide Y1-receptor with reduced sizeDenise Zwanziger, Ilka Böhme, Diana Lindner, et al.
Journal of Receptor and Signal Transduction Research|November 23, 2006
Localization of novel adiponectin receptor constructsCornelia M Deckert, John T Heiker, Annette G Beck-Sickinger
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Biased agonists at the human Y<sub>1</sub> receptor lead to prolonged membrane residency and extended receptor G protein interactionAnette Kaiser, Lizzy Wanka, Isabelle Ziffert, et al.
Neuropeptides|October 2, 2012
The anterograde transport of the human neuropeptide Y2 receptor is regulated by a subtype specific mechanism mediated by the C-terminusCornelia Walther, Jonathan Lotze, Annette G Beck-Sickinger, et al.
Chembiochem : a European Journal of Chemical Biology|May 15, 2023
Stable Binding of Full-Length Chemerin Is Driven by Negative Charges in the CMKLR1 N TerminusKevin Kretschmer, Tristan Zellmann, Karin Mörl, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 7, 2024
Targeted modulation of gene expression through receptor-specific delivery of small interfering RNA peptide conjugatesMareike Schenk, Karin Mörl, Stephan Herzig, et al.
ACS Applied Bio Materials|November 16, 2024
Design and Biofunctionalization of Cloud Sponge-Inspired Scaffolds for Enhanced Bone Cell PerformancePhilipp Zimmermann, Peter Schulze, Annette G Beck-Sickinger, et al.
Chemmedchem|September 30, 2022
The Chemerin Receptor CMKLR1 Requires Full-Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase-Based Binding AssayAnne Sophie Czerniak, Kevin Kretschmer, Tina Weiß, et al.
Chembiochem : a European Journal of Chemical Biology|September 9, 2011
Simultaneous "one pot" expressed protein ligation and CuI-catalyzed azide/alkyne cycloaddition for protein immobilizationMax Steinhagen, Kai Holland-Nell, Morten Meldal, et al.
Pageof 31

Showing results (81-90 of 309) with videos related to

Sort By:
Pageof 31
Future Medicinal Chemistry|August 25, 2012
Peptides and peptide conjugates: therapeutics on the upward pathVerena M Ahrens, Kathrin Bellmann-Sickert, Annette G Beck-Sickinger
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 6, 2009
First selective agonist of the neuropeptide Y1-receptor with reduced sizeDenise Zwanziger, Ilka Böhme, Diana Lindner, et al.
Journal of Receptor and Signal Transduction Research|November 23, 2006
Localization of novel adiponectin receptor constructsCornelia M Deckert, John T Heiker, Annette G Beck-Sickinger
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Biased agonists at the human Y<sub>1</sub> receptor lead to prolonged membrane residency and extended receptor G protein interactionAnette Kaiser, Lizzy Wanka, Isabelle Ziffert, et al.
Neuropeptides|October 2, 2012
The anterograde transport of the human neuropeptide Y2 receptor is regulated by a subtype specific mechanism mediated by the C-terminusCornelia Walther, Jonathan Lotze, Annette G Beck-Sickinger, et al.
Chembiochem : a European Journal of Chemical Biology|May 15, 2023
Stable Binding of Full-Length Chemerin Is Driven by Negative Charges in the CMKLR1 N TerminusKevin Kretschmer, Tristan Zellmann, Karin Mörl, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 7, 2024
Targeted modulation of gene expression through receptor-specific delivery of small interfering RNA peptide conjugatesMareike Schenk, Karin Mörl, Stephan Herzig, et al.
ACS Applied Bio Materials|November 16, 2024
Design and Biofunctionalization of Cloud Sponge-Inspired Scaffolds for Enhanced Bone Cell PerformancePhilipp Zimmermann, Peter Schulze, Annette G Beck-Sickinger, et al.
Chemmedchem|September 30, 2022
The Chemerin Receptor CMKLR1 Requires Full-Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase-Based Binding AssayAnne Sophie Czerniak, Kevin Kretschmer, Tina Weiß, et al.
Chembiochem : a European Journal of Chemical Biology|September 9, 2011
Simultaneous "one pot" expressed protein ligation and CuI-catalyzed azide/alkyne cycloaddition for protein immobilizationMax Steinhagen, Kai Holland-Nell, Morten Meldal, et al.
Pageof 31